Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial
Authors
Keywords
Biomarkers, Fibrosis, Liver fibrosis, Fatty liver, Fats, Liver diseases, Magnetic resonance imaging, Liver and spleen scan
Journal
PLoS One
Volume 13, Issue 9, Pages e0203054
Publisher
Public Library of Science (PLoS)
Online
2018-09-08
DOI
10.1371/journal.pone.0203054
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A multicenter, randomized, double-blind, PLB-controlled trial of Galectin-3 inhibitor (GR-MD-02) in patients with NASH cirrhosis and portal hypertension
- (2018) N. Chalasani et al. JOURNAL OF HEPATOLOGY
- Role of imaging-based biomarkers in NAFLD: Recent advances in clinical application and future research directions
- (2018) Rohit Loomba JOURNAL OF HEPATOLOGY
- Multiparametric magnetic resonance imaging for quantitation of liver disease: a two-centre cross-sectional observational study
- (2018) Natasha McDonald et al. Scientific Reports
- Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity
- (2017) Michael Pavlides et al. LIVER INTERNATIONAL
- Transaminase abnormalities and adaptations of the liver lobule manifest at specific cut-offs of steatosis
- (2017) Andrew Hall et al. Scientific Reports
- Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis
- (2016) S. A. Harrison et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice
- (2016) Parambir S. Dulai et al. JOURNAL OF HEPATOLOGY
- A model for hepatic fibrosis: the competing effects of cell loss and iron on shortened modified Look-Locker inversion recoveryT1(shMOLLI-T1) in the liver
- (2016) Elizabeth M. Tunnicliffe et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 Diabetes
- (2016) Eylem Levelt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE
- (2015) I. Doycheva et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Diagnostic Performance of Magnetic Resonance Elastography in Staging Liver Fibrosis: A Systematic Review and Meta-analysis of Individual Participant Data
- (2015) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- Quantitative magnetic resonance imaging of hepatic steatosis: Validation inex vivohuman livers
- (2015) Peter Bannas et al. HEPATOLOGY
- Ezetimibe for the treatment of nonalcoholic steatohepatitis: Assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)
- (2015) Rohit Loomba et al. HEPATOLOGY
- Non-invasive assessment of liver fibrosis with impulse elastography: Comparison of Supersonic Shear Imaging with ARFI and FibroScan®
- (2014) Christophe Cassinotto et al. JOURNAL OF HEPATOLOGY
- Non-invasive evaluation of liver fibrosis: a comparison of ultrasound-based transient elastography and MR elastography in patients with viral hepatitis B and C
- (2013) Anneloes E. Bohte et al. EUROPEAN RADIOLOGY
- Human non-contrast T1 values and correlation with histology in diffuse fibrosis
- (2013) Sacha Bull et al. HEART
- Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials
- (2013) Mazen Noureddin et al. HEPATOLOGY
- Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease
- (2013) Rajarshi Banerjee et al. JOURNAL OF HEPATOLOGY
- Role of magnetic resonance elastography in compensated and decompensated liver disease
- (2013) Sumeet K. Asrani et al. JOURNAL OF HEPATOLOGY
- Therapy of Experimental NASH and Fibrosis with Galectin Inhibitors
- (2013) Peter G. Traber et al. PLoS One
- Regression of Fibrosis and Reversal of Cirrhosis in Rats by Galectin Inhibitors in Thioacetamide-Induced Liver Disease
- (2013) Peter G. Traber et al. PLoS One
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- When Galectins Recognize Glycans: From Biochemistry to Physiology and Back Again
- (2011) Santiago Di Lella et al. BIOCHEMISTRY
- Will the increased prevalence of nonalcoholic steatohepatitis (NASH) in the age of better hepatitis C virus therapy make NASH the deadlier disease?
- (2011) Mary E. Rinella HEPATOLOGY
- Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: A prospective study
- (2011) Marie Angèle Robic et al. JOURNAL OF HEPATOLOGY
- Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
- (2010) Christopher D. Williams et al. GASTROENTEROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started